Press
CoEHAR’s RESEARCH SET NEW GUIDELINES FOR THE DOSAGE OF NICOTINE IN LIQUIDS
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
Italy: Annual Report of Italian Customs and Monopoly reveals a drastic drop in cigarette sales
Presented in Italy the “Blue Book”, the document containing the results achieved last year by the Italian Customs and Monopoly Agency. The most impressive result was the contraction of 6.80% in...
A study by CoHEAR reveals antibacterial properties in e-cigarette liquids
According to a study lead by CoEHAR of the University of Catania, the e-liquids used in electronic cigarettes have antibacterial properties effective on different pathogens
PARTNERSHIPS BETWEEN COHEAR, DUKE UNIVERSITY, OASI OF TROINA LEADS TO THE FIRST STUDY TO EVALUATE THE CORRELATION BETWEEN SMOKING HABITS AND COVID-19 INFECTIONS.
In the past few days, seroepidemiological tests on citizens have been performed to assess the impact of smoking on the Covid-19 infections on the most vulnerable part of the population. The subjects of the study were selected according to a multi-layered probabilistic sampling plan by gender and age on citizens from 5 to over 80 years old. Among them, the employees of the Oasi of Troina, many of whom were tested positive to the Covid-19 infection.
Harm reduction is a flavoured journey in global tobacco control
New studies show flavoured vaping products are more effective for adults who want to quit smoking for good without relapsing.
THE NEW FRONTIERS OF REHABILITATION: VIRTUAL REALITY CAN HELP PEOPLE WITH SCHIZOPHRENIA SPECTRUM DISORDERS
A Systematic Review conducted by the researchers of the University of Catania and COEHAR suggests that Immersive Virtual Reality can be used to treat symptoms related to the spectrum of schizophrenia.
Incriminating ecig no matter what is becoming a new national sport
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
QUIT STRONG: New Zealand bets on vaping to quit smoking
QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking
The Smile Study has officially started the operational phase
On 22 July 2020, Smile Study started officially the operational phase of the projects with the training on the equipments and the visiting of first subjects enrolledDr. Elbert Waller of the Inspektor Research Systems has been welcomed in Catania for for the conduction of a training on the latest innovative technologies in dental diagnostic
Do You really know what Tobacco Harm Reduction is?
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
The new Vaping Manual between Science and Real Use
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.
Replica Project: the Trip through all the Partners
The Coehar Director, Giovanni Li Volti and the Co-project Leader for Replica, Dr. Massimo Caruso have organized a tour to all the international partners of the project to harmonize the protocols of the study for the first year of the Replica Project
Replica Project Partnership: A Trip to Oman
The Replica Project aim is to replicate the most important studies in the field of Tobacco Harm Reduction (THR)The following video refers to one of the stop of the Replica Tour: Giovanni Li Volti and the Co-project Leader Massimo Caruso were in Oman.
Smoking and COVID-19: hospitalized smokers are far fewer than expected but have more severe disease
A new study published in the journal “Therapeutic Advances in Chronic Disease” provides important insight to the issue of smoking and COVID-19. The number of smokers with severe COVID-19 that requires hospitalization is by far lower than expected based on population smoking rates. The very few smokers who are eventually hospitalized have higher odds for severe disease and adverse outcome.
Smokers, former smokers, never smokers and vapers: a survey by the COEHAR explains their behavior during the lockdown
The findings from a survey conducted by COEHAR researchers on almost 2000 participants showed a slight decrease in the consumption of cigarettes during the lockdown period and an increase in the purchase of products such as cigarettes and e-liquid
The Global Forum on Nicotine 2020 moves online
The organisers of the Global Forum on Nicotine (GFN), KAC Communications, are launching an online version of GFN20 which will take place on Thursday 11 and Friday 12 June following the cancellation of the face-to-face event in Warsaw due to COVID-19
COEHAR UNICT: A call is open for 4 Research Fellowships
Catania, 8 June 2020 – The selection procedure for the award of 4 Research Fellowships is open to young graduates in various discipline: the deadline is June 26, 2020. The selection is part of the activities and research projects promoted by the COEHAR, the Center of Excellence for the Accelleration of Harm Reduction of the University of Catania, founded by Prof. Riccardo Polosa.